| Characteristic | Share of total public drug spending |
|---|---|
| Antineoplastic and immunomodulating agents | 23.3% |
| Alimentary tract and metabolism | 15.6% |
| Nervous system | 14.5% |
| Cardiovascular system | 8.9% |
| Respiratory system | 7.3% |
| Sensory organs | 6.4% |
| Blood and blood-forming organs | 5.4% |
| Anti-infectives for systemic use | 4.6% |
| Musculoskeletal system | 2.8% |
| Genitourinary system and sex hormones | 1.9% |
| Systemic hormonal preparations (excl. sex hormones and insulins) | 1.5% |
| Dermatologicals | 0.9% |
| Anti-parasitic products, insecticides and repellents | 0.1% |
| Various | 0.8% |
| Unassigned* | 1.5% |
| Non-drug products** | 4.4% |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Loading statistic...
Download
Source
Source
Release date
November 2023
More information
Region
Canada
Survey time period
2022
Supplementary notes
Currently, the Northwest Territories and Nunavut do not submit data to NPDUIS.
* This category includes products without an assigned Anatomical Therapeutic Chemical (ATC) code.
** Non-drug products include, but are not limited to, diabetic supplies, wound care, ostomy supplies and pharmaceutical services.
Citation formats
